1993
DOI: 10.1016/s0022-3476(05)81705-6
|View full text |Cite
|
Sign up to set email alerts
|

A randomized, controlled trial of platelet transfusions in thrombocytopenic premature infants

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

8
185
0
6

Year Published

2004
2004
2017
2017

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 235 publications
(199 citation statements)
references
References 33 publications
8
185
0
6
Order By: Relevance
“…In this study, giving platelet transfusions to infants with a platelet count of less than 150 000 did shorten bleeding times but did not reduce the incidence or extent of IVH. 15 In our population of VLBW infants, those with IVH, severe IVH and severe IVH and/or death were more likely to have platelet mass <10th percentile in the first 2 days of life, but platelet mass did not differ on the day of birth. IVH in premature infants occurs within the first week of life, with the majority occurring within the first 4 days.…”
Section: Discussionmentioning
confidence: 66%
“…In this study, giving platelet transfusions to infants with a platelet count of less than 150 000 did shorten bleeding times but did not reduce the incidence or extent of IVH. 15 In our population of VLBW infants, those with IVH, severe IVH and severe IVH and/or death were more likely to have platelet mass <10th percentile in the first 2 days of life, but platelet mass did not differ on the day of birth. IVH in premature infants occurs within the first week of life, with the majority occurring within the first 4 days.…”
Section: Discussionmentioning
confidence: 66%
“…22 They are also recommended as prophylaxis against bleeding if the count falls sufficiently low. [23][24][25] Precisely how low to permit a platelet count to fall in an ELBW neonate before ordering a platelet transfusion is not known. We found that platelet transfusions were nearly always given for prophylaxis against bleeding rather than to treat active bleeding.…”
Section: Discussionmentioning
confidence: 99%
“…52 neurological damage or death. [53][54][55][56] To correct an abnormal platelet count, the cause of the thrombocytopenia should be taken into account.…”
Section: Recombinant Erythropoietinmentioning
confidence: 99%